COVID-19 Related Coagulopathy
novel coronavirus of zoonotic origin named “severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)” emerged at the end of 2019, in Wuhan province of China. The infection called COVID-19 was declared by World Health Organization a global pandemic. Coronavirüs disease-2019 (COVID-19) is frequent...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayincilik
2020-12-01
|
| Series: | Namık Kemal Tıp Dergisi |
| Subjects: | |
| Online Access: |
http://namikkemalmedj.com/archives/archive-detail/article-preview/covd-19-related-coagulopathy/43278
|
| _version_ | 1797916910604517376 |
|---|---|
| author | Seval AKPINAR |
| author_facet | Seval AKPINAR |
| author_sort | Seval AKPINAR |
| collection | DOAJ |
| description | novel coronavirus of zoonotic origin named “severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)” emerged at the end of 2019, in Wuhan province of China. The infection called COVID-19 was declared by World Health Organization a global pandemic. Coronavirüs disease-2019 (COVID-19) is frequently associated with a hypercoagulable state as a result of endothelial injury, stasis and increased levels of circulating protrombotic factors. Especially patients in intensive care units have an increased risk for venous thromboembolism despite prophylactic anticoagulant treatment. In this review, we summarized current data regarding pathophysiology, coagulation parameters, evaluation and management of COVID-19 associated coagulopathy. |
| first_indexed | 2024-04-10T13:04:50Z |
| format | Article |
| id | doaj.art-62895794e5bb4c0eb2f4e10452f79432 |
| institution | Directory Open Access Journal |
| issn | 2587-0262 |
| language | English |
| last_indexed | 2024-04-10T13:04:50Z |
| publishDate | 2020-12-01 |
| publisher | Galenos Yayincilik |
| record_format | Article |
| series | Namık Kemal Tıp Dergisi |
| spelling | doaj.art-62895794e5bb4c0eb2f4e10452f794322023-02-15T16:13:00ZengGalenos YayincilikNamık Kemal Tıp Dergisi2587-02622020-12-018356456910.37696/nkmj.77216213049054COVID-19 Related CoagulopathySeval AKPINAR0 Tekirdağ Namık Kemal Üniversitesi İç Hastalıkları Anabilim Dalı Hematoloji Bilim Dalı, Tekirdağ, TÜRKİYE novel coronavirus of zoonotic origin named “severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)” emerged at the end of 2019, in Wuhan province of China. The infection called COVID-19 was declared by World Health Organization a global pandemic. Coronavirüs disease-2019 (COVID-19) is frequently associated with a hypercoagulable state as a result of endothelial injury, stasis and increased levels of circulating protrombotic factors. Especially patients in intensive care units have an increased risk for venous thromboembolism despite prophylactic anticoagulant treatment. In this review, we summarized current data regarding pathophysiology, coagulation parameters, evaluation and management of COVID-19 associated coagulopathy. http://namikkemalmedj.com/archives/archive-detail/article-preview/covd-19-related-coagulopathy/43278 covid-19thromboembolismthrombosisintravascular coagulation |
| spellingShingle | Seval AKPINAR COVID-19 Related Coagulopathy Namık Kemal Tıp Dergisi covid-19 thromboembolism thrombosis intravascular coagulation |
| title | COVID-19 Related Coagulopathy |
| title_full | COVID-19 Related Coagulopathy |
| title_fullStr | COVID-19 Related Coagulopathy |
| title_full_unstemmed | COVID-19 Related Coagulopathy |
| title_short | COVID-19 Related Coagulopathy |
| title_sort | covid 19 related coagulopathy |
| topic | covid-19 thromboembolism thrombosis intravascular coagulation |
| url |
http://namikkemalmedj.com/archives/archive-detail/article-preview/covd-19-related-coagulopathy/43278
|
| work_keys_str_mv | AT sevalakpinar covid19relatedcoagulopathy |